Several studies on this page
- The effect of vitamin D deficiency on eradication rates of Helicobacter pylori infection - Dec 2018
- The influence of vitamin D deficiency on eradication rates of Helicobacter pylori - 2017
- Helicobacter pylori infection 3X higher risk if less than 20 of Vitamin D – Sept 2018
- Metabolic Syndrome 2.1X more likely if both Helicobacter pylori Infection and <20 ng of Vitamin D – May 2016
Successful if high Vitamin D
JGH Open. 2018 Aug 2;2(6):270-275. doi: 10.1002/jgh3.12081. eCollection 2018 Dec.
El Shahawy MS1, Hemida MH2, El Metwaly I3, Shady ZM1.
Many studies have investigated risk factors other than antibiotic resistance linked to Helicobacter pylori (H. pylori) eradication failure. The aim of this study was to study the effect of serum levels of 25-hydroxy-vitamin D (25OHD) on eradication rates of H. pylori infection.
This study included 150 patients diagnosed with H. pylori gastritis using magnifying narrow-band imaging endoscopy supported by stool antigen test. Serum 25-OH vitamin D levels were measured via the Enzyme-Linked Immune Sorbent assay (ELISA) method before starting eradication therapy of H. pylori infection. All patients were treated with clarithromycin-based triple therapy for 14 days. H. pylori eradication was determined via a stool antigen test performed 4 weeks after the end of therapy. According to the serum level of 25-OH vitamin D levels, the patients were divided into two groups: group I (sufficient) had a vitamin D level of ≥20 ng/mL, while group II (deficient) had a vitamin D level of <20 ng/mL.
Our results revealed that eradication was successful in 105 (70%) patients and failed in 45 (30%) patients. The mean 25[OH]D level was significantly lower in the eradication failure group compared to the successful treatment group (14.7 ± 4.5 vs 27.41 ± 7.1; P < 0.001).
Furthermore, there were significantly more patients with deficient 25[OH]D levels in the failed treatment group, 30 (66.6%), compared to the successful group, 10 (9.5%) (P < 0.001).
Our results demonstrated that 25-OH vitamin D deficiency may be considered a risk factor related to eradication failure of H. pylori infection. In addition, a further randomized trial to evaluate the effect of vitamin D supplementation in H. pylori eradication is mandatory.
Download the PDF from VitaminDWiki
Adv Clin Exp Med. 2017 Dec;26(9):1377-1381. doi: 10.17219/acem/65430.
Yildirim O1, Yildirim T2, Seckin Y1, Osanmaz P3, Bilgic Y1, Mete R4.
1 Department of Gastroenterology, Faculty of Medicine, Inonu University, Malatya, Turkey.
2 Dept of Physiotherapy and Rehabilitation, Faculty of Medicine, Inonu University, Malatya, Turkey.
3 Department of Internal Medicine, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
4 Department of Gastroenterology, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Eradicated: 19 ng of vitamin D
NOT eradicated: 9 ng of vitamin D
- This Vitamin Shown to Be Almost 10 Times More Effective Than the Flu Shot – Feb 2017
- Having less than 15 ng of vitamin D increased risk of hospitalization with infection by 2.8 times – April 2016
- 8 times less bacteria in blood of HIV patients if Vitamin D levels greater than 30 ng – April 2016
- Vitamin D improves a child’s immune system – can now be claimed in Europe – Sept 2016
- Inflammatory diseases: review of vitamin D, with many tables – May 2014
- Helicobacter pylori infection protection by the body’s increasing Vitamin D receptors – Nov 2013
See also PubMed
Helicobacter pylori eradication therapy improves the healing of various gastro-duodenal diseases such as chronic gastritis and peptic ulcer, and also reduces gastric cancer incidence. Several studies have reported on risk factors other than antibiotic resistance related to Helicobacter pylori eradication failure.
In this study, we aimed to investigate whether or not the serum levels of 25-hydroxy-vitamin D (25(OH)D) influence eradication rates of H.pylori.
MATERIAL AND METHODS:
220 patients diagnosed with H.pylori gastritis using endoscopic biopsy had their 25-OH vitamin D levels measured via the electrochemiluminescence method before beginning eradication therapy of H.pylori. Gastric biopsies obtained at endoscopy were examined for H.pylori strains and histopathologic findings. All patients were treated with bismuth-containing quadruple therapy for 14 days. H.pylori eradication was determined via the 14C-urea breath test performed 4 weeks after the end of therapy. Based on the 25-OH vitamin D levels, the patients were divided into 2 groups: group 1 (deficient) had a vitamin D level of <10 ng/mL, while group 2 (sufficient) had a vitamin D level of ≥10 ng/ mL.
Eradication was successful in 170 (77.2%) patients and failed in 50 (22.7%) patients. The prevalence of 25(OH)D deficiency was 30.5%. Mean 25(OH)D levels were significantly lower in the eradication failure group compared to the successful treatment group (9.13 ±4.7 vs 19.03 ±8.13; p = 0.001). There were significantly more patients with deficient 25(OH)D levels in the failed treatment group compared to the successful treatment group (p = 0.001).
Our findings suggest that 25-OH vitamin D deficiency may be considered a risk factor related to eradication failure of H.pylori, which may lead to a need for supplementation of vitamin D before eradication of H.pylori.
Vitamin D deficiency and risk of Helicobacter pylori infection in older adults: a cross-sectional study.
Aging Clin Exp Res. 2018 Sep 28. doi: 10.1007/s40520-018-1039-1. [Epub ahead of print]
Mut Surmeli D1, Surmeli ZG2, Bahsi R3, Turgut T3, Selvi Oztorun H3, Atmis V4, Varli M3, Aras S3.
1 Department of Geriatrics, Ibni-i Sina Hospital, Ankara University School of Medicine, 06230, Ankara, Turkey. denizmut19 at yahoo.com.
2 Department of Medical Oncology, Ankara Medical Park Hospital, 06680, Ankara, Turkey.
3 Department of Geriatrics, Ibni-i Sina Hospital, Ankara University School of Medicine, 06230, Ankara, Turkey.
4 Department of Geriatrics, Bursa Sevket Yilmaz Training and Research Hospital, 16310, Bursa, Turkey.
Vitamin D deficiency is known to cause increased predisposition to various infectious diseases and the addition of vitamin D to antimicrobial treatment may improve treatment responses. However, the relationship between vitamin D and Helicobacter pylori (H. pylori) remains to be determined.
AIMS: To assess the association between vitamin D deficiency and H. pylori infection.
This cross-sectional study included patients aged 65 and over, who underwent gastroscopy and had gastric biopsy performed between 2010 and 2017. Of the 441 patients, 254 had available 25-hydroxyvitamin D level results and were included in the analyses. Patients were categorized into H. pylori (+) and H. pylori (-) groups, according to histopathological examination results of gastric biopsies. Serum 25(OH) vitamin D levels less than 20 ng/mL were defined as vitamin D deficiency.
Of all patients, 43 were H. pylori (+) and 211 were H. pylori (-). More patients had vitamin D deficiency (< 20 ng/mL) in the H. pylori (+) group than the H. pylori (-) group (86% vs 67.3%, p = 0.014). The proportion of H. pylori (+) patients decreased across increasing quartiles of 25(OH) vitamin D levels (p for trend = 0.010). In multivariable logistic regression analysis, vitamin D deficiency was associated with increased odds of H. pylori infection after adjustment for age, gender, and Charlson Comorbidity Index (OR = 3.02, 95% CI 1.19-7.69, p = 0.020).
Vitamin D deficiency can be associated with increased risk of H. pylori infection. The potential protective effect of vitamin D against H. pylori infection and its possible role in the treatment of H. pylori should be evaluated in prospective trials.
Metabolic Syndrome 2.1X more likely if both Helicobacter pylori Infection and <20 ng of Vitamin D – May 2016
The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based Study.
Medicine (Baltimore). 2016 May;95(18):e3616. doi: 10.1097/MD.0000000000003616.
Chen LW1, Chien CY, Hsieh CW, Chang LC, Huang MH, Huang WY, Kuo SF, Chien CH, Lin CL, Chien RN.
The associations between Helicobacter pylori infection, serum vitamin D level, and metabolic syndrome (MS) are controversial. The present community-based study aimed to investigate the effect of H pylori infection and serum vitamin D deficiency on MS development.Individuals from the northeastern region of Taiwan were enrolled in a community-based study from March, 2014 to August, 2015. All participants completed a demographic survey and underwent the urea breath test (UBT) to detect H pylori infection as well as blood tests to determine levels of vitamin D, adiponectin, leptin, and high-sensitivity C-reactive protein. The ATP III criteria for MS were used in this study. A total of 792 men and 1321 women were enrolled. The mean age was 56.4 ± 13.0 years. After adjusting for age and sex, the estimated odds of MS development for a UBT-positive subject were 1.503 (95% confidence interval CI: 1.206-1.872, P < 0.001) when compared to a UBT-negative subject.
For participants with vitamin D deficiency (<20 ng/mL), the odds of MS development were 1.423 (95% CI: 1.029-1.967, P = 0.033) when compared to those with sufficient vitamin D level (>30 ng/mL).
For participants with both H pylori infection and vitamin D deficiency, the odds of MS development were 2.140 (95% CI: 1.348-3.398, P = 0.001) when compared to subjects without H pylori infection and with sufficient vitamin D levels.H pylori infection and vitamin D deficiency could be predictors of MS.
For individuals with both H pylori infection and vitamin D deficiency, the odds of MS development were 2.140 when compared to individuals without H pylori infection and with sufficient vitamin D levels.
Items in both categories Metabolic Syndrome and Immunity are listed here: